The global Oral Proteins & Peptides Market , valued at US$7.35 billion in 2024, is forecasted to grow at a robust CAGR of ...

Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...

Highlights Semaglutide medications like Ozempic may cause facial changes. You can take steps to help minimize or prevent ...

Rights Aug 28, 1995 Sep 20, 1995 Aug 24, 1995 Rights ratio: 1 share for every 1 held at a price of Rs 45.0 Rights Jan 28, 1994 Feb 22, 1994 Jan 27, 1994 Rights ratio: 1 share for every 1 held at a ...